PenderFund Capital Management’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

PenderFund Capital Management’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,300	Closed	-$271K	–	162
2024 Q1	$271K	Buy	+9,300	New	+$61.7K	0.07%	83

PenderFund Capital Management's LABP Position: Q2 2024 in Review

PenderFund Capital Management sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2024, closing a stake of 9,300 shares — an estimated $271K sold.

PenderFund Capital Management first reported a position in LABP in Q1 2024 and held it in 1 quarter. The position peaked at $271K in Q1 2024. 0 funds tracked by Wall St. Rank hold LABP as of Q2 2024.

PenderFund Capital Management reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
PenderFund Capital Management sold 9,300 Landos Biopharma, Inc. Common Stock shares in Q2 2024, an estimated $271K.
PenderFund Capital Management first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
PenderFund Capital Management's Landos Biopharma, Inc. Common Stock position peaked at $271K in Q1 2024.
0 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2024.

Based on PenderFund Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.